Benjamin P Erickson, MD
Ophthalmology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Erickson’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A141640 · Current
Licensed to practise in California · since 2016 · expires 2027-05-31 · Yale University School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Florida ME120046Medical Doctor · since 2014 · expires 2018-01-31Null And VoidNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Yale School of Medicine · Masters Degree2008–2010
- Yale School of Medicine · MD2005–2010Medical school
- Harvard University · Bachelor Degree2000–2004
Residency and fellowship
- Bascom Palmer Eye Institute, OphthalmologyMIAMI, FL · 2011–2014
- Lankenau Medical Center, Internal MedicineWYNNEWOOD, PA · 2010–2011
Medicaid work
$0 in 2023
Medicaid paid $0 for 15 billed services this clinician did in 2023, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 15 | $0 |
| 2023 | 15 | 1 | 15 | $0 |
| 2022 | 14 | 1 | 14 | $0 |
| 2021 | 57 | 1 | 26 | $2,004 |
| 2020 | 40 | 2 | 14 | $717 |
| 2019 | 100 | 3 | 14 | $3,310 |
| 2018 | 25 | 2 | 13 | $1,204 |
See the largest Medicaid services in earlier years
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 14 | $0 |
2021
| Return visit (30+ min) | 57 | $2,004 |
2020
| Short return visit (20+ min) | 28 | $520 |
| Return visit (30+ min) | 12 | $198 |
2019
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 26 | $1,787 |
| Short return visit (20+ min) | 62 | $1,376 |
| Return visit (30+ min) | 12 | $147 |
2018
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $965 |
| Short return visit (20+ min) | 13 | $239 |
Drugs they prescribed that Part D paid
$5,756
Pharmacies billed $5,756 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 462) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
457 generic and fewer than 11 brand-name prescriptions · $5,756 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Neomycin-Polymyxin-Dexameth | 217 | $3,783 | $12 |
| Erythromycin | 70 | $1,467 | $14 |
Year by year
| 2024 | 462 | 274 | 0% (0) | None | $5,756 |
| 2023 | 575 | 310 | 0% (0) | None | $8,543 |
| 2022 | 472 | 271 | None | 9% | $8,220 |
| 2021 | 277 | 142 | None | 37% | $8,750 |
| 2020 | 197 | 94 | None | 36% | $7,128 |
| 2019 | 333 | 150 | None | 29% | $9,425 |
| 2018 | 264 | 140 | None | 27% | $3,919 |
| 2017 | 283 | 123 | 4% (12) | 38% | $7,637 |
| 2016 | 166 | 92 | 8% (13) | 43% | $9,075 |
| 2015 | 115 | 64 | 25% (29) | 23% | $3,676 |
| 2014 | 71 | 29 | None | None | $1,606 |
| 2013 | 35 | None | 0% (0) | 43% | $2,231 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Neomycin-Polymyxin-Dexameth | 345 | $4,086 | $12 |
| Erythromycin | 168 | $2,547 | $15 |
| Methylprednisolone | 17 | $166 | $10 |
2022: 3 drugs
| Neomycin-Polymyxin-Dexameth | 312 | $3,837 | $12 |
| Erythromycin | 91 | $1,299 | $14 |
| Methylprednisolone | 13 | $131 | $10 |
2021: 3 drugs
| Neomycin-Polymyxin-Dexameth | 183 | $3,054 | $17 |
| Erythromycin | 33 | $394 | $12 |
| Methylprednisolone | 12 | $124 | $10 |
2020: 2 drugs
| Neomycin-Polymyxin-Dexameth | 96 | $1,708 | $18 |
| Erythromycin | 41 | $449 | $11 |
2019: 7 drugs
| Tobradex | 14 | $3,253 | $232 |
| Neomycin-Polymyxin-Dexameth | 142 | $2,165 | $15 |
| Erythromycin | 64 | $777 | $12 |
| Fluticasone Propionate | 12 | $193 | $16 |
| Methylprednisolone | 11 | $137 | $12 |
| Polymyxin B Sul-Trimethoprim | 11 | $101 | $9 |
| Cephalexin | 13 | $72 | $6 |
2018: 2 drugs
| Neomycin-Polymyxin-Dexameth | 141 | $1,938 | $14 |
| Erythromycin | 52 | $565 | $11 |
2017: 3 drugs
| Neomycin-Polymyxin-Dexameth | 161 | $2,529 | $16 |
| Erythromycin | 30 | $290 | $10 |
| Methylprednisolone | 11 | $137 | $12 |
2016: 1 drug
| Neomycin-Polymyxin-Dexameth | 68 | $1,123 | $17 |
2015: 3 drugs
| Bacitracin-Polymyxin | 15 | $334 | $22 |
| Neomycin-Polymyxin-Dexameth | 12 | $171 | $14 |
| Oxycodone-Acetaminophen | 16 | $134 | $8 |
2014: 1 drug
| Prednisolone Acetate | 13 | $707 | $54 |
Money from drug and device companies
$92 in 2024
| 2024 | 1 | 1 | None | $92 |
| 2023 | 1 | 1 | None | $143 |
| 2019 | 3 | 3 | None | $213 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $92 | 1 payment
|
See the published payment
| Abbvie | Meals · 2024-10-04 | Botox | $92 |
See earlier years (2023, 2019)
2023: $143
| Horizon Therapeutics plc | Tepezza | $143 | 1 payment
|
2019: $213
| Mallinckrodt Enterprises | Acthar | $120 | 1 payment
|
| Stryker | Universal Upper-Face | $81 | 1 payment
|
| Osteomed | Cmf-Cfx | $11 | 1 payment
|
Professional record
- NPI
- 1942529144
- Licence
- CA 141640, FL ME120046California A141640: Current · expires 2027-05-31Florida ME120046: Null And Void
- Trained
- Yale University School of Medicine, 2009
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1804 Embarcadero Rd, Ste 100, Palo Alto, CA, 94303
- NPI first listed
- 2010-05-27
- NPI last updated
- 2022-05-27
- NPI record certified
- 2022-05-27
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.